Response to Epinephrine in Children Receiving Oral β-Agonists

Dennis Randall Ownby, John Anderson

Research output: Contribution to journalArticle

Abstract

Physicians are sometimes concerned that the regular use of oral β-agonists in the outpatient management of childhood asthma will result in decreased sensitivity or tachyphylaxis to these agents. While tachyphylaxis might not be clinically important during outpatient treatment, it could become significant during the emergency treatment of acute asthmatic attacks. We compared the increase in peak flow measurements before and 20 minutes after the injection of subcutaneous epinephrine hydrochloride in children with acute asthma and found no significant differences between those patients taking and those not taking oral β-agonists.

Original languageEnglish (US)
Pages (from-to)122-123
Number of pages2
JournalAmerican Journal of Diseases of Children
Volume140
Issue number2
DOIs
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Tachyphylaxis
Epinephrine
Outpatients
Asthma
Emergency Treatment
Subcutaneous Injections
Physicians
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Response to Epinephrine in Children Receiving Oral β-Agonists. / Ownby, Dennis Randall; Anderson, John.

In: American Journal of Diseases of Children, Vol. 140, No. 2, 01.01.1986, p. 122-123.

Research output: Contribution to journalArticle

@article{8df715a8b9444c9593b3660d40f7a106,
title = "Response to Epinephrine in Children Receiving Oral β-Agonists",
abstract = "Physicians are sometimes concerned that the regular use of oral β-agonists in the outpatient management of childhood asthma will result in decreased sensitivity or tachyphylaxis to these agents. While tachyphylaxis might not be clinically important during outpatient treatment, it could become significant during the emergency treatment of acute asthmatic attacks. We compared the increase in peak flow measurements before and 20 minutes after the injection of subcutaneous epinephrine hydrochloride in children with acute asthma and found no significant differences between those patients taking and those not taking oral β-agonists.",
author = "Ownby, {Dennis Randall} and John Anderson",
year = "1986",
month = "1",
day = "1",
doi = "10.1001/archpedi.1986.02140160040026",
language = "English (US)",
volume = "140",
pages = "122--123",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Response to Epinephrine in Children Receiving Oral β-Agonists

AU - Ownby, Dennis Randall

AU - Anderson, John

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Physicians are sometimes concerned that the regular use of oral β-agonists in the outpatient management of childhood asthma will result in decreased sensitivity or tachyphylaxis to these agents. While tachyphylaxis might not be clinically important during outpatient treatment, it could become significant during the emergency treatment of acute asthmatic attacks. We compared the increase in peak flow measurements before and 20 minutes after the injection of subcutaneous epinephrine hydrochloride in children with acute asthma and found no significant differences between those patients taking and those not taking oral β-agonists.

AB - Physicians are sometimes concerned that the regular use of oral β-agonists in the outpatient management of childhood asthma will result in decreased sensitivity or tachyphylaxis to these agents. While tachyphylaxis might not be clinically important during outpatient treatment, it could become significant during the emergency treatment of acute asthmatic attacks. We compared the increase in peak flow measurements before and 20 minutes after the injection of subcutaneous epinephrine hydrochloride in children with acute asthma and found no significant differences between those patients taking and those not taking oral β-agonists.

UR - http://www.scopus.com/inward/record.url?scp=0022639920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022639920&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1986.02140160040026

DO - 10.1001/archpedi.1986.02140160040026

M3 - Article

VL - 140

SP - 122

EP - 123

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 2

ER -